JOHNSON & JOHNSON

Official Publications Johnson & Johnson Bulgaria S.E.

Equities

JNJ

US4781601046

Real-time Estimate Tradegate Other stock markets 15:35:02 27/06/2024 BST			5-day change	1st Jan Change
137 ^EUR	-1.30%		+1.86%	-12.66%

12:39pm	US FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug	RE
06-24	US Supreme Court gives pharma companies a chance to thwart terrorism-funding lawsuit	RE

Official Publications

SEC Filing 10Q-2	28/07/22	CO
Slide show half-year results	18/07/22	CO
1st-half-year results	18/07/22	CO
SEC Filing 8K	18/07/22	CO
Dividends	17/07/22	CO
SEC Filing 10Q-1	28/04/22	CO
SEC Filing 8K	27/04/22	CO
Slide show Q1	18/04/22	CO
SEC Filing 8K	18/04/22	CO
1st quarter results	18/04/22	CO
SEC Filing 8K	05/01/22	CO

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 05:30 pm

Protect and grow your investments with the help of our experts

Securing my Investments

fermer